SCHEMBL13769018

SCHEMBL13769018

CC[C@]12CCC3C4CC/C(=N\O)C=C4CCC3C1CCC21CCC(=O)O1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1I2 O75469 2/20 0.63
▸ PGR P06401 7/20 0.59
▸ SLC6A4 P31645 4/20 0.59
▸ NR3C1 P04150 2/20 0.59
▸ ADORA3 P0DMS8 1/20 0.59
▸ SLC6A2 P23975 1/20 0.59
▸ AGTR1 P30556 1/20 0.59
▸ DRD3 P35462 1/20 0.59
▸ SLC6A3 Q01959 1/20 0.59
▸ PDE4D Q08499 1/20 0.59
▸ PDK1 Q15118 4/20 0.53
▸ PDK2 Q15119 4/20 0.53
▸ PDK3 Q15120 4/20 0.53
▸ PDK4 Q16654 4/20 0.53
▸ AR P10275 6/20 0.51
▸ LMNA P02545 3/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ CYP3A4 P08684 2/20 0.50
▸ KMT2A Q03164 2/20 0.50
▸ ESR1 P03372 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12949523 0.87 PGR (0.66) PGRSLC6A4NR3C1ARLMNA
SCHEMBL16404180 0.81 PGR (0.78) NR1I2PGRSLC6A4NR3C1ADORA3
SCHEMBL22382702 0.81 NR1I2 (0.74) NR1I2PGRSLC6A4NR3C1ADORA3
SCHEMBL12942957 0.80 PGR (0.57) NR1I2PGRSLC6A4NR3C1ADORA3
Norelgestromin SCHEMBL4814600 0.77 NR1I2 (1.00) NR1I2PGRSLC6A4NR3C1ADORA3
SCHEMBL13306245 0.77 NR1I2 (0.78) NR1I2PGRSLC6A4NR3C1ADORA3
Norelgestromin SCHEMBL4814611 0.77 NR1I2 (1.00) NR1I2PGRSLC6A4NR3C1ADORA3
Norelgestromin SCHEMBL3267125 0.77 NR1I2 (1.00) NR1I2PGRSLC6A4NR3C1ADORA3
Norelgestromin SCHEMBL118611 0.77 NR1I2 (1.00) NR1I2PGRSLC6A4NR3C1ADORA3
Norelgestromin SCHEMBL3163347 0.77 NR1I2 (1.00) NR1I2PGRSLC6A4NR3C1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009083266-A1 17-HYDROXY-19-NOR-21-CARBOXYLIC ACID-STEROID γ-LACTONE DERIVATIVE, USE THEREOF, AND MEDICAMENT CONTAINING THE DERIVATIVE BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-07-09 — — WO disclosed
Send feedback